Synthetic Minds | Pharma Companies Are Quietly Becoming Compute Companies
Roche now runs 3,500+ NVIDIA GPUs on premises for drug discovery — pharma's largest GPU cluster. Lilly committed $2.75B to an AI platform that generates drugs. Insilico's CEO says the shift is from licensing molecules to licensing infrastructure. Pharma is not adopting technology. It is becoming it.
Read More